Drawing for Anxiety
(D&A Trial)
Trial Summary
What is the purpose of this trial?
Anxiety is among the most common emotional difficulties impacting well-being, highlighting the need for approachable anxiety-reduction tools. Both mindfulness and art-based interventions have been shown to decrease anxiety symptoms. These studies integrate these approaches via a novel guided drawing intervention, and tests effects on anxiety (pre/post drawing and at one-week follow-up) and physiological regulation (respiratory sinus arrhythmia). This registration includes two separate intervention studies with similar protocols but using different samples - one consisting of adolescents ages 13 to 17.9 years, and the other consisting of adults ages 18 to 25 years. Participants complete a laboratory visit during which they complete questionnaires about their emotions and anxiety, complete pre/post measures of cardiac physiology and state anxiety, and engage in a drawing session. Participants also complete a one-week follow-up self-report of anxiety symptoms. The intervention protocol is briefly described as follows: participants in each sample are randomly assigned to one of three groups (guided drawing, free drawing control, or basic control).
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on drawing activities for anxiety, so it's unlikely that medication changes are required.
What data supports the effectiveness of the Guided Drawing Intervention treatment for anxiety?
Is drawing therapy safe for managing anxiety in humans?
How is the Guided Drawing Intervention treatment for anxiety different from other treatments?
Guided Drawing Intervention is unique because it uses drawing as a therapeutic tool to help manage anxiety, which is different from traditional treatments like medication or talk therapy. This approach focuses on creative expression to reduce anxiety, making it a novel option for those who may benefit from non-verbal therapeutic methods.12457
Research Team
Sarah Myruski, PhD
Principal Investigator
The Pennsylvania State University
Eligibility Criteria
This study is for adolescents aged 13 to 17.9 years and young adults aged 18 to 25 years who experience anxiety. Participants will be asked about their emotions, engage in a drawing session, and report on their anxiety levels before, after, and one week following the intervention.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Laboratory Visit
Participants complete questionnaires, cardiac monitoring, and a drawing session
Follow-up
Participants complete a one-week follow-up self-report of anxiety symptoms
Treatment Details
Interventions
- Guided Drawing Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Penn State University
Lead Sponsor